Expert Suggestion for Diabetes Management During the Recent COVID-19 Pandemic
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Smudja M, Milenkovic T, Minakovic I, Zdravkovic V, Mitic S, Milutinovic D Nurs Open. 2023; 10(11):7394-7410.
PMID: 37688291 PMC: 10563408. DOI: 10.1002/nop2.1993.
Cutruzzola A, Parise M, Fiorentino R, Romano A, Molinaro V, Gnasso A Nutrients. 2022; 14(16).
PMID: 36014822 PMC: 9414780. DOI: 10.3390/nu14163316.
References
1.
Yonekawa A, Shimono N
. Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B.1.1.529). Biology (Basel). 2022; 11(3).
PMC: 8945151.
DOI: 10.3390/biology11030400.
View
2.
Menni C, Valdes A, Polidori L, Antonelli M, Penamakuri S, Nogal A
. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022; 399(10335):1618-1624.
PMC: 8989396.
DOI: 10.1016/S0140-6736(22)00327-0.
View
3.
Seiglie J, Platt J, Cromer S, Bunda B, Foulkes A, Bassett I
. Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19. Diabetes Care. 2020; 43(12):2938-2944.
PMC: 7770271.
DOI: 10.2337/dc20-1506.
View
4.
Wang W, Lu J, Gu W, Zhang Y, Liu J, Ning G
. Care for diabetes with COVID-19: Advice from China. J Diabetes. 2020; 12(5):417-419.
DOI: 10.1111/1753-0407.13036.
View
5.
Zhang Y, Wang W, Ning G
. Metabolic Management Center: An innovation project for the management of metabolic diseases and complications in China. J Diabetes. 2018; 11(1):11-13.
DOI: 10.1111/1753-0407.12847.
View